CISO Stock – What Investors Should Know Cerberus Cyber Sentinel Corp. (CISO Stock) is a cybersecurity and compliance company offering cybersecurity consulting and related services. Cerberus Cyber Sentinel Corporation specializes in cybersecurity and compliance. The company offers secured managed services, compliance services, security operations center (SOC) services, virtual Chief Information […]
Due Diligence
31 posts
SNTG Stock – What Investors Should Know About Sentage Holdings Inc Sentage Holdings Inc (SNTG Stock) is a Chinese financial services company providing a wide range of financial services in the People’s Republic of China. These include consumer loan repayment and collection management, loan recommendation, and prepaid payment network services. […]
CLNV Stock: What Investors Should Know About Clear Vision Corp. Clear Vision Corp (CLNV Stock) is a multinational holding company that acquires and operates sustainable clean technology and green energy enterprises. The company offers clean technology solutions that are focused on sustainability and renewable energy. It provides market-based wind power, […]
FCUV Stock: Analysis – Due Diligence – Risk Factors Focus Universal, Inc. (FCUV Stock) develops and manufactures smart hardware devices, integration software, and a Universal Smart Instrumentation Platform (USIP). Focus Universal Inc. is a provider of patented hardware and software design technologies for the Internet of Things (IoT) and 5G. […]
CYBL Stock: Overview Cyberlux Corp. (CYBL Stock) creates, manufactures, and sells long-term portable lighting devices for commercial and industrial users. Cyberlux operates in the Industrials sector and Electrical Equipment industry. The company provides sophisticated, yet lightweight, portable battery-powered LED lighting solutions. These products meet the demanding needs of special operators, forward-base operations, […]
NBIO Stock: Overview Nascent Biotech (NBIO Stock) is a clinical-stage biopharmaceutical firm developing monoclonal antibodies for the treatment of various cancers. The company focuses on biological therapeutic candidates that are now undergoing or have recently finished their first clinical testing. Particular emphasis is devoted to producing and administering human antibodies […]